Pyrazolines: A biological review

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 6, 2013, Pages 921-931

  Marella, Akranth ^a   Ali, Md Rahmat ^a   Alam, Md Tauquir ^a   Saha, Rikta ^a   Tanwar, Omprakash ^a   Akhter, Mymoona ^a   Shaquiquzzaman, Md ^a   Alam, M Mumtaz ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Heterocyclic; Pharmacological activities; Pyrazoline

Indexed keywords

ACETYLCHOLINESTERASE; CANNABINOID 1 RECEPTOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPLERENONE; ERYTHROMYCIN; METRONIDAZOLE; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; PYRAZINAMIDE; PYRAZOLINE DERIVATIVE; SELEGILINE; SEROTONIN 6 ANTAGONIST; SEROTONIN RECEPTOR; SILYMARIN; STREPTOMYCIN;

ANALGESIC ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; CARDIOVASCULAR EFFECT; CENTRAL NERVOUS SYSTEM; HUMAN; NONHUMAN; REVIEW; TUBERCULOSIS;

ANALGESICS; ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ANTIPROTOZOAL AGENTS; CARDIOVASCULAR AGENTS; CENTRAL NERVOUS SYSTEM; HUMANS; HYPOGLYCEMIC AGENTS; MONOAMINE OXIDASE INHIBITORS; PYRAZOLES;

EID: 84876700618     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557511313060012     Document Type: Review

References (97)

1. Sharma, P.K.; Kumar, S.; Kumar, P.; Kaushik, P.; Kaushik, D.; Dhingra, Y.; Aneja, K.R. Synthesis and biological evaluation of some pyrazolylpyrazolines as anti-inflammatory-antimicrobial agents. Eur. J. Med. Chem., 2010, 45, 2650-2655.
2. Rathish, I.G.; Javed, K.; Ahmad, S.; Bano, S.; Alam, M.S.; Pillai, K.K.; Singh, S.; Bagchi, V. Synthesis and antiinflammatory activity of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulphonamide. Bioorg. Med. Chem. Lett., 2009, 19, 255-258.
3. Chandra, T.; Garg, N.; Lata, S.; Saxena, K.K.; Kumar, A. Synthesis of substituted acridinyl pyrazoline derivatives and their evaluation for anti-inflammatory activity. Eur. J. Med. Chem., 2010, 45, 1772-1776.
4. Kaplancikli, Z.A.; Zitouni, G.A.; Ozdemir, A.; Can, O.D.; Chevallet, P. Synthesis and antinociceptive activities of some pyrazoline derivatives. Eur. J. Med. Chem., 2008, 44, 2606-2610.
5. Khode, S.; Maddi, V.; Aragade, P.; Palkar, M.; Ronad, P.K.; Mamledesai, S.; Thippeswamy, A.H.M.; Satyanarayana, D. Synthesis and pharmacological evaluation of a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1 phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents. Eur. J. Med. Chem., 2009, 44, 1682-1688.
6. Reddy, M.V.R.; Billa, V.K.; Pallela, V.R.; Mallireddigari, M.R.; Boominathan, R.; Gabriel, J.L.; Reddy, E.P. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Bioorg. Med. Chem., 2008, 16, 3907-3916.
7. Fioravanti, R.; Bolasco, A.; Manna, F.; Rossi, F.; Orallo, F.; Ortuso, F.; Alcaro, S.; Cirilli, R. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors. Eur. J. Med. Chem., 2010, 45, 6135-6138.
8. Sahu, S.K.; Banerjee, M.; Samantray, A.; Behera, C.; Azam, M.A. Synthesis, analgesic, anti-inflammatory and antimicrobial activities of some novel pyrazoline derivatives. Trop. J. Pharm. Res., 2008, 7, 961-968.
9. Joshi, R.S.; Mandhane, P.G.; Diwakar, S.D.; Dabhade, S.K.; Gill, C.H. Synthesis, analgesic and anti-inflammatory activities of some novel pyrazolines derivatives. Bioorg. Med. Chem. Lett., 2010, 20, 3721-3725.
10. Amir, M.; Kumar, H.; Khan, S.A. Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents. Bioorg. Med. Chem. Lett., 2008, 18, 918-922.
11. Barsoum, F.F.; Hosni, H.M.; Girgis, A.S. Novel bis(1-acyl-2-pyrazolines) of potential anti-inflammatory and molluscicidal properties. Bioorg. Med. Chem., 2006, 14, 3929-3937.
12. Bano, S.; Javed, K.; Ahmad, S.; Rathish, I.G.; Singh, S.; Alam, M.S. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur. J. Med. Chem., 2011, 46, 5763-5768.
13. Bashir, R.; Ovais, S.; Yaseen, S.; Hamid, H.; Alam, M.S.; Samim, M.; Singh, S.; Javed, K. Synthesis of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agents. Bioorg. Med. Chem. Lett., 2011, 21, 4301-4305.
14. Lange, J.H.M.; van der Neut, M.A.W.; den Hartog, A.P.; Wals, H.C.; Hoogendoorn, J.; van Stuivenberg, H.H.; van Vliet, B.J.; Kruse, C.G. Synthesis, SAR and intramolecular hydrogen bonding pattern of 1,3,5-trisubstituted 4,5-dihydropyrazoles as potent cannabinoid CB1 receptor antagonists. Bioorg. Med. Chem. Lett., 2010, 20, 1752-1757.
15. Khode, S.; Maddi, V.; Aragade, P.; Palkar, M.; Ronad, P.K.; Mamledesai, S.; Thippeswamy, A.H.M. Satyanarayana, D. Synthesis and pharmacological evaluation of a novel series of 5-(substituted) aryl-3-(3-coumarinyl)-1-phenyl-2 pyrazolines as novel anti-inflammatory and analgesic agents. Eur. J. Med. Chem., 2009, 44, 1682-1688.
16. Ozkay, U.D.; Can, O.D.; Kaplancikli, Z.A. Antinociceptive activities of some triazole and pyrazoline moieties-bearing compounds. Med. Chem. Res., 2012, 21, 1056-1061.
17. Burguete, A.; Pontiki, E.; Hadjipavlou-Litina, D.; Ancizu, S.; Villar, R.; Solano, B.; Moreno, E.; Torres, E.; Perez, S.; Aldana, I.; Monge, A. Synthesis and biological evaluation of new quinoxaline derivatives as antioxidant and anti-inflammatory agents. Chem. Biol. Drug Des., 2011, 77, 255-267.
18. Samshuddin, S.; Narayana, B.; Sarojini, B.K.; Khan, M.T.H.; Yathirajan, H.S.; Raj, C.G.D.; Raghavendra, R. Antimicrobial, analgesic, DPPH scavenging activities and molecular docking study of some 1,3,5-triaryl-2-pyrazolines. Med. Chem. Res., 2012, 21, 2012-2022.
19. Ovais, S.; Bashir, R.; Yaseen, S.; Rathore, P.; Samim, M.; Javed, K. Synthesis and pharmacological evaluation of some novel 2-pyrazolines bearing benzenesulfonamide as anti-inflammatory and blood glucose lowering agents. Med. Chem. Res., 2012, doi: 10.1007/s00044-012-0130-y.
20. Girisha, K.S.; Kalluraya, B.; Narayana, V.; Padmashree. Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline. Eur. J. Med. Chem., 2010, 45, 4640-4644.
21. Carradori, S.; Secci, D.; Bolasco, A.; de Monte, C.; Yanez, M. Synthesis and selective inhibitory activity against human COX-1 of novel 1-(4-substituted-thiazol-2-yl)-3,5-di(hetero)aryl-pyrazoline derivatives. Arch. Chem. Pharm-Chem. Life Sci., 2012, 354, 973-979.
22. Hu, L.; Lan P.; Song, Q.A.; Huang, Z.J.; Sun, P.H.; Zhuo, C.; Wang, Y.; Xiao, S.; Chen, W.M. Synthesis and antibacterial activity of C-12 pyrazolinyl spiro ketolides. Eur. J. Med. Chem., 2010, 45, 5943-5949.
23. Rani, M.; Yusuf, M.; Khan, S.A. Synthesis and in-vitro-antibacterial activity of [5-(furan-2-yl)-phenyl]-4,5-carbothioamide-pyrazolines. J. Saudi Chem. Soc., 2011, 16, 431-436.
24. Rani, M.; Yusuf, M.; Khan, S.A.; Sahota, P.P.; Pandove, G. Synthesis, studies and in-vitro antibacterial activity of N-substituted 5-(furan-2-yl)-phenyl pyrazolines. Arabian J. Chem., 2011, doi:10.1016/j.arabjc.2010.10.036.
25. Rani, M.; Mohamad, Y. Synthesis, studies and in-vitro antibacterial activity of some 5-(thiophene-2-yl)-phenyl pyrazoline derivatives. J. Saudi Chem. Soc., 2011, doi:10.1016/j.jscs.2011.09.002.
26. Solankee, A.; Prajapati, Y. An efficient synthesis of some new fluorine containing acetyl pyrazoline and isoxazole derivatives and their antibacterial activity. Rasayan J. Chem., 2009, 2, 23-27.
27. Konda, S.G.; Valekar, A.H.; Lomate, S.T.; Lokhande, P.D.; Dawane, B.S. Synthesis and antibacterial studies of some new pyrazoline and isoxazoline derivatives. J. Chem. Pharm. Res., 2010, 2, 1-6.
28. Agrawal, M.; Sonar, P.K.; Saraf, S.K. Synthesis of 1,3,5-trisubstituted pyrazoline nucleus containing compounds and screening for antimicrobial activity. Med. Chem. Res., 2011, 21, 3376-3381.
29. Munawar, M.A.; Azad, M.; Athar, M.; Groundwater, P.W. Synthesis and antimicrobial activity of quinoline-based 2-pyrazolines. Chem. Pap., 2008, 62, 288-293.
30. Deng, H.; Yu, Z.Y.; Shi, G.Y.; Chen, M.J.; Tao, K.; Hou, T.P. Synthesis and in-vitro antifungal evaluation of 1,3,5-trisubstituted-2-pyrazoline derivatives. Chem. Biol. Drug. Des., 2012, 79, 279-289.
31. Kumar, S.; Meenakshi; Kumar, S.; Kumar, P. Synthesis and antimicrobial activity of some (3-phenyl-5-(1-phenyl-3-aryl-1H-pyrazol-4-yl)-4,5-dihydro-1H-pyrazol-1-yl)(pyridin-4-yl)methanones: new derivatives of 1,3,5-trisubstituted pyrazolines. Med. Chem. Res. 2013, 22, 433-439.
32. Rostom, S.A.F.; Badr, M.H.; Abd El Razik, H.A.; Ashour, H.M.A.; Abdel Wahab, A.E. Synthesis of some pyrazolines and pyrimidines derived from polymethoxy chalcones as anticancer and antimicrobial agents. Arch. Pharm., 2011, 344, 572-587.
33. Siddiqui, Z.N.; Musthafa, T.N.M.; Ahmad, A.; Khan, A.U. Thermal solvent-free synthesis of novel pyrazolyl chalcones and pyrazolines as potential antimicrobial agents. Bioorg. Med. Chem. Lett., 2011, 21, 2860-2865.
34. Jadhav, S.B.; Shastri, R.A.; Gaikwad, K.V.; Gaikwad, S.V. Synthesis and antimicrobial studies of some novel pyrazoline and isoxazoline derivatives. E-Journal of Chemistry, 2009, 6, 183-188.
35. Wahab, B.F.A.; Latif, E.A.; Mohamed, H.A.; Awad, G.E.A. Design and synthesis of new 4-pyrazolin-3-yl-1,2,3-triazoles and 1,2,3-triazol-4-ylpyrazolin-1-ylthiazoles as potential antimicrobial agents. Eur. J. Med. Chem., 2012, 52, 263-268.
36. 2-pyrazolines. Arabian J. Chem., 2011, doi:10.1016/j.arabjc.2011.06.015.
37. Chaitanya, S.K.; Ishwar, B.K.; Revanna S.B.C.; Satyanarayana, D.; Kalluraya, B. Synthesis and biological activity studies of some pyrazoline derivatives containing quinoline moiety. J. Ind. Council Chem., 2009, 26, 37-40.
38. Dawane, B.S.; Konda, S.G.; Mandawad, G.G.; Shaikh, B.M. Poly(ethylene glycol) (PEG-400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4'-chlorophenyl)-2-thiazolyl)-3-aryl-5-(2-butyl-4-chloro-1H-imidazol-5yl)-2-pyrazolines and their in-vitro antimicrobial evaluation. Eur. J. Med. Chem., 2010, 45, 387-392.
39. Zhao, P.L.; Wang, F.; Zhang, M.Z.; Liu, Z.M.; Huang, W.; Yang, G.F. Synthesis, fungicidal, and insecticidal activities of - Methoxyacrylate-containing N-acetyl pyrazoline derivatives. J. Agric. Food Chem., 2008, 56, 10767-10773.
40. Havrylyuk, D.; Zimenkovsky, B.; Vasylenko, O.; Zaprutko, L.; Gzella, A.; Lesyk, R. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Eur. J. Med. Chem., 2009, 44, 1396-1404.
41. Shaharyar, M.; Abdullah, M.M.; Bakht, M.A.; Majeed, J. Pyrazoline bearing benzimidazoles: Search for anticancer agent. Eur. J. Med. Chem., 2010, 45, 114-119.
42. Parekh, S.; Bhavsar, D.; Savant, M.; Thakrar, S.; Bavishi, A.; Parmar, M.; Vala, H.; Radadiya, A.; Pandya, N.; Serly, J.; Molnar, J.; Shah, A. Synthesis of some novel benzofuran-2-yl(4,5-dihyro-3,5-substituted diphenylpyrazol-1-yl) methanones and studies on the antiproliferative effects and reversal of multidrug resistance of human MDR1-gene transfected mouse lymphoma cells in-vitro. Eur. J. Med. Chem., 2011, 46, 1942-1948.
43. Insuasty, B.; Garcia, A.; Quiroga, J.; Abonia, R.; Ortiz, A.; Nogueras, M.; Cobo, J. Efficient microwave-assisted synthesis and antitumor activity of novel 4,4'-methylenebis[2-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)phenols]. Eur. J. Med. Chem., 2011, 46, 2436-2440.
44. Insuasty, B.; Tigreros, A.; Orozco, F.; Quiroga, J.; Abonia, R.; Nogueras, M.; Sanchez, A.; Cobo, J. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents. Bioorg. Med. Chem., 18, 2010, 4965-4974.
45. Johnson, M.; Younglove, B.; Lee, L.; LeBlanc, R.; Holt, H.; Hills, P.; Mackay, H.; Brown, T.; Mooberry, S.L.; Lee, M. Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4. Bioorg. Med. Chem. Lett., 2007, 17, 5897-5901.
46. Lee, M.; Brockway, O.; Dandavati, A.; Tzou, S.; Sjoholm, R.; Satam, V.; Westbrook, C.; Mooberry, S.L.; Zeller, M.; Babu, B.; Lee, M. A novel class of trans-methylpyrazoline analogs of combretastatins: Synthesis and in-vitro biological testing. Eur. J. Med. Chem., 2011, 46, 3099-3104.
47. Bandaya, A.H.; Mir, B.P.; Lone, I.H.; Suri, K.A.; Kumar, H.M.S. Studies on novel D-ring substituted steroidal pyrazolines as potential anticancer agents. Steroids, 2010, 75, 805-809.
48. Shaharyar, M.; Siddiqui, A.A.; Ali, M.A.; Murugan, V.; Chandrashekhar, R. Synthesis and cytotoxic activity of novel pyrazoline derivatives against human lung tumor cell line (A549). J. Chin. Chem. Soc.-Taip., 2007, 54, 81-86.
49. Khalil, N.A.; Ahmed, E.M.; El-Nassan, H.B. Synthesis, characterization, and biological evaluation of certain 1,3-thiazolone derivatives bearing pyrazoline moiety as potential anti-breast cancer agents. Med. Chem Res., 2012, doi: 10.1007/s00044-012-0098-7.
50. Bai, X.; Shi, W.Q.; Chen, H.F.; Zhang, P.; Li, Y.; Yin, S.F. Synthesis and antitumor activity of 1-acetyl-3-(4-phenyl)-4,5-dihydro-2-pyrazoline-5-phenylursolate and 4-chalcone ursolate derivatives. Chem. Nat. Compd., 2012, doi:10.1007/s10600-012-0159-7.
51. Aziz, M.A.; Aly, O.M.; Khan, S.S.; Mukherjee, K.; Bane, S. Synthesis, cytotoxic properties and tubulin polymerization inhibitory activity of novel 2-pyrazoline derivatives. Arch. Pharm. Life Sci., 2012, 345, 535-548.
52. Insuasty, B.; Chamizo, L.; Munoz, J.; Tigreros, A.; Quiroga, J.; Abonia, R.; Nogueras, M.; Cobo, J. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity. Arch. Pharm. Chem. Life Sci., 2012, 345, 275-286.
53. Taj, T.; Kamble, R.R.; Gireesh, T.M.; Hunnur, R.K.; Margankop, S.B. One-pot synthesis of pyrazoline derivatised carbazoles as antitubercular, anticancer agents, their DNA cleavage and antioxidant activities. Eur. J. Med. Chem., 2011, 46, 4366-4373.
54. Ali, M.A.; Shaharyar, M.; Siddiqui, A.A. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Eur. J. Med. Chem., 2007, 42, 268-275.
55. 1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines. Bioorg. Med. Chem. Lett., 2006, 16, 3947-3949.
56. Kasabe, A.J.; Kasabe, P.J. Synthesis, anti-tubercular and analgesic activity evaluation of new 3-pyrazoline derivatives. Int. J. Pharmacy Pharm. Sci., 2010, 2, 132-135.
57. Sivakumar, P.M.; Seenivasan, S.P.; Kumar, V.; Doble, M. Novel 1,3,5-triphenyl-2-pyrazolines as anti-infective agents. Bioorg. Med. Chem. Lett., 2010, 20, 3169-3172.
58. Khudina, O.G.; Burgart, Y.V.; Saloutin, V.I.; Kravchenko, M.A. One-pot synthesis of trifluoromethyl-and nitroso-substituted pyrazolines and pyrazoles and their tuberculostatic activity. Russ. Chem. Bull., 2010, 59, 1967-1973.
59. Manna, K.; Agrawal, Y.K. Potent in-vitro and in-vivo antitubercular activity of certain newly synthesised indophenazine 1,3,5-trisubstitutedpyrazoline derivatives bearing benzofuran. Med. Chem. Res., 2011, 20, 300-306.
60. Hayat, F.; Salahuddin, A.; Umar, S.; Azam, A. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel series of pyrazoline derivatives bearing quinoline tail. Eur. J. Med. Chem., 2010, 45, 4669-4675.
61. Adhikari, N.; Maiti, M.K.; Jha, T. Exploring structural requirements of 1-N-substituted thiocarbamoyl-3-phenyl-2-pyrazolines as antiamoebic agents using comparative QSAR modelling. Bioorg. Med. Chem. Lett., 2010, 20, 4021-4026.
62. Abid, M.; Bhat, A.R.; Athar, F.; Azam, A. Synthesis, spectral studies and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3-phenyl-2-pyrazolines. Eur. J. Med. Chem., 2009, 44, 417-425.
63. Husain, K.; Abid, M.; Azam, A. Novel Pd(II) complexes of 1-N-substituted 3-phenyl-2-pyrazoline derivatives and evaluation of antiamoebic activity. Eur. J. Med. Chem., 2008, 43, 393-403.
64. Bhat, A.R.; Athar, F.; Azam, A. Bis-pyrazolines: synthesis, characterization and antiamoebic activity as inhibitors of growth of Entamoeba histolytica. Eur. J. Med. Chem., 2009, 44, 426-431.
65. Mbarki, S.; Dguigui, K.; Hallaoui, M.E. Construction of 3D-QSAR models to predict antiamoebic activities of pyrazoline and dioxazoles derivatives. J. Mater. Environ. Sci., 2011, 2, 61-70.
66. Singh, P.; Negi, J.S.; Rawat, M.S.M.; Pant G.J. Synthesis, antiamoebic activity and thermal study of copper complexes of 1-formyl-2-pyrazolines. J. Therm. Anal. Calorim., 2012, doi: 10.1007/s10973-011-2168-3.
67. Rizvi, S.U.F.; Siddiqui, H.L.; Ahmad, M.N.; Ahmad, M.; Bukhari, M.H. Novel quinolyl-thienyl chalcones and their 2-pyrazoline derivatives with diverse substitution pattern as antileishmanial agents against Leishmania major. Med. Chem. Res., 2012, 21, 1322-1333.
68. Du, X.; Guo, C.; Hansell, E.; Doyle, P.S.; Caffrey, C.R.; Holler, T.P.; McKerrow, J.H.; Cohen, F.E. Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain. J. Med. Chem., 2002, 45, 2695-2707.
69. Aher, R.B.; Wanare, G.; Kawathekar, N.; Kumar, R.R.; Kaushik, N.K.; Sahal, D.; Chauhan, V.K. Dibenzylideneacetone analogues as novel Plasmodium falciparum inhibitors. Bioorg. Med. Chem. Lett., 21, 2011, 3034-3036.
70. Acharya, B.N.; Saraswat, D.; Tiwari, M.; Shrivastava, A.K.; Ghorpade, R.; Bapna, S.; Kaushik, M.P. Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines. Eur. J. Med. Chem., 2010, 45, 430-438.
71. Rizvi, S.U.F.; Siddiqui, H.L.; Johns, M.; Detorio, M.; Schinazi, R.F. Anti-HIV-1 and cytotoxicity studies of piperidyl-thienyl chalcones and their 2-pyrazolines derivatives. Med. Chem. Res., 2011, 21, 3741-3749.
72. Goodell, J.R., Basagoiti, F.P.; Forshey, B.M.; Shi, P.Y.; Ferguson, D.M. Identification of compounds with anti-West Nile virus activity. J. Med. Chem., 2006, 49, 2127-2137.
73. Ramajayam, R.; Tan, K.P.; Liu, H.G.; Liang, P.H. Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors. Bioorg. Med. Chem., 2010, 18, 7849-7854.
74. Meyers, M.J.; Arhancet, G.B.; Hockerman, S.L.; Chen, X.; Long, S.A.; Mahoney, M.W.; Rico, J.R.; Garland, D.J.; Blinn, J.R.; Collins, J.T.; Yang, S.; Huang, H.C.; McGee, K.F.; Wendling, J.M.; Dietz, J.D.; Payne, M.A.; Homer, B.L.; Heron, M.I.; Reitz, D.B.; Hu, X. Discovery of (3S,3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy. J. Med. Chem., 2010, 53, 5979-6002.
75. Jeong, T.S.; Kim, K.S.; An, S.J.; Cho, K.H.; Lee, S.; Lee, W.S. Novel 3,5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors. Bioorg. Med. Chem. Lett., 2004, 14, 2715-2717.
76. Enein, M.N.A.; El-Azzouny, A.A.; Attia, M.I.; Maklad, Y.A.; Amin, K.M.; Rehim, M.A.; El-Behairy, M.F. Design and synthesis of novel stiripentol analogues as potential anticonvulsants. Eur. J. Med. Chem., 2012, 47, 360-369.
77. Siddiqui, A.A.; Rahman, M.A.; Shaharyar, M.; Mishra, R. Synthesis and anticonvulsant activity of some substituted 3,5-diphenyl-2-pyrazoline-1-carboxamide derivatives. Chemical Sciences Journal, Volume 2010: CSJ-8.
78. Ozdemir, Z.; Kandilci, H.B.; Gumusel, B.; Calis, U.; Bilgin, A.A. Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives. Eur. J. Med. Chem., 2007, 42, 373-379.
79. Kaplancikli, Z.A.; Ozdemir, A.; Zitouni, G.T.; Altintop, M.D.; Can, O.D. New pyrazoline derivatives and their antidepressant activity. Eur. J. Med. Chem., 2010, 45, 4383-4387.
80. Can, O.D.; Ozkay, U.D.; Kaplancikli, Z.A.; Ozturk, Y. Effects of some 1,3,5-trisubstituted-2-pyrazoline derivatives on depression and anxiety parameters of mice. Arch. Pharm. Res., 2009, 32, 1293-1299.
81. Gok, S.; Demet, M.M.; Ozdemir, A.; Zitouni, G.T. Evaluation of antidepressant-like effect of 2-pyrazoline derivatives. Med. Chem. Res., 2010, 19, 94-101.
82. van Loevezijn, A.; Venhorst, J.; Bakker, W.I.I.; de Korte, C.G.; de Looff, W.; Verhoog, S.; van Wees, J.W.; van Hoeve, M.; van de Woestijne, R.P.; van der Neut, M.A.W.; Borst, A.J.M.; van Dongen, M.J.P.; de Bruin, N.M.W.J.; Keizer, H.G.; Kruse, C.G. N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT6R) antagonists with unique structural features. J. Med. Chem., 2011, 54, 7030-7054.
83. Latif, N.A.A.; Sabry, N.M.; Mohamed, A.M.; Abdulla, M.M. Synthesis, analgesic, and antiparkinsonian profiles of some pyridine, pyrazoline, and thiopyrimidine derivatives. Monatsh. Chem., 2007, 138, 715-724.
84. Das, N.; Dash, B.; Dhanawat, M.; Shrivastava, S.K. Design, synthesis, preliminary pharmacological evaluation, and docking studies of pyrazoline derivatives. Chem. Pap., 2012, 66, 67-74.
85. Mishra, N.; Sasmal, D. Development of selective and reversible pyrazoline based MAO-B inhibitors: Virtual screening, synthesis and biological evaluation. Bioorg. Med. Chem. Lett., 2011, 21, 1969-1973.
86. Jagrat, M.; Behera, J.; Yabanoglu, S.; Ercan, A.; Ucar, G.; Sinha, B.N.; Sankaran, V.; Basu, A.; Jayaprakash, V. Pyrazoline based MAO inhibitors: Synthesis, biological evaluation and SAR studies. Bioorg. Med. Chem. Lett., 2011, 21, 4296-4300.
87. Sahoo, A.; Yabanoglu, S.; Sinha, B.N.; Ucar, G.; Basu, A.; Jayaprakash, V. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies. Bioorg. Med. Chem. Lett., 2010, 20, 132-136.
88. Jayaprakash, V.; Sinha, B.N.; Ucar, G.; Ercan, A. Pyrazoline-based mycobactin analogues as MAO-inhibitors. Bioorg. Med. Chem. Lett., 2008, 18, 6362-6368.
89. Kelekci, N.G.; Koyunoglu, S.; Yabanoglu, S.; Yelekci, K.; Ozgen, O.; Ucar, G.; Erol, K.; Kendi, E.; Yesilada, A. New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. Bioorg. Med. Chem., 17, 2009, 675-689.
90. Chimenti, F.; Carradori, S.; Secci, D.; Bolasco, A.; Bizzarri, B.; Chimenti, P.; Granese, A.; Yanez, M.; Orallo, F. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives. Eur. J. Med. Chem., 2010, 45, 800-804.
91. Karuppasamy, M.; Mahapatra, M.; Yabanoglu, S.; Ucar, G.; Sinha, B.N.; Basu, A.; Mishra, N.; Sharon, A.; Kulandaivelu, U.; Jayaprakash, V. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies. Bioorg. Med. Chem., 2010, 18, 1875-1881.
92. Fioravanti, R.; Bolasco, A.; Manna, F.; Rossi, F.; Orallo, F.; Yanez, M.; Vitali, A.; Ortuso, F.; Alcaro, S. Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors. Bioorg. Med. Chem. Lett., 2010, 20, 6479-6482.
93. Secci, D.; Bolasco, A.; Chimenti, P.; Carradori, S. The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents. Current Medicinal Chemistry, 2011, 18, 5114-5144.
94. Jun, M.A.; Park, W.S.; Kang, S.K.; Kim, K.Y.; Kim, K.R.; Rhee, S.D.; Bae, M.A.; Kang, N.S.; Sohn, S.K.; Kim, S.G.; Lee, J.O.; Lee, D.H.; Cheon, H.G.; Kim, S.S.; Ahn, J.H. Synthesis and biological evaluation of pyrazoline analogues with -amino acyl group as dipeptidyl peptidase IV inhibitors. Eur. J. Med. Chem., 2008, 43, 1889-1902.
95. Khalilullah, H.; Khan, S.; Ahsan, M.J.; Ahmed, B. Synthesis and antihepatotoxic activity of 5-(2,3-dihydro-1,4-benzodioxane-6-yl)-3 substituted-phenyl-4,5-dihydro-1H-pyrazole derivatives. Bioorg. Med. Chem. Lett., 2011, 21, 7251-7254.
96. van Loevezijn, A.; Venhorst, J.; Bakker, W.I.I.; de Korte, C.G.; de Looff, W.; Verhoog, S.; van Wees, J.W.; van Hoeve, M.; van de Woestijne, R.P.; van der Neut, M.A.W.; Borst, A.J.M.; van Dongen, M.J.P.; de Bruin, N.M.W.J.; Keizer, H.G.; Kruse, C.G. N'-(Arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5 HT6R) antagonists with unique structural features. J. Med. Chem., 2011, 54, 7030-7054.
97. Lange, J.H.M.; Coolen, H.K.A.C.; van der Neut, M.A.W.; Borst, A.J.M.; Stork, B.; Verveer, P.C.; Kruse, C.G. Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonism. J. Med. Chem., 2010, 53, 1338-1346.